Short Interest in Psykey, Inc. (OTCMKTS:CEOS) Increases By 1,142.6%

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 29,822 shares, a growth of 1,142.6% from the June 30th total of 2,400 shares. Based on an average daily trading volume, of 1,023,946 shares, the short-interest ratio is currently 0.0 days.

Psykey Stock Performance

Shares of CEOS remained flat at $0.01 during mid-day trading on Friday. Psykey has a 52-week low of $0.00 and a 52-week high of $0.01. The stock’s 50-day moving average price is $0.01.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.